Design (Testphase)
Quality & Balance Sheet
Fundamental Rank (A / A+)
35
Hits
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 35 hits from US
Our own Fundamental Rating (0…100 points, rank A+…F; 50 points = the average of the universe) in the style of professional screener platforms: every stock is percentile-ranked against all others — historical & recent EPS/revenue growth (EPS = earnings per share), EPS surprise, forward EPS, plus quality (acceleration, margin + margin expansion, Piotroski, FCF, earnings stability, OCF positivity, balance sheet safety, return on equity ROE, forward revenue growth), plus a bonus for improvement across quarters. Shows rank A/A+ (from 75 points), sorted by rating. Still pending more data: only revenue surprise remains outstanding.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- ROE (Return on Equity)
- Profit divided by equity: how much return does the company generate on its owners' money? Consistently above 15-20% is considered a hallmark of top-tier companies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
- Surprise (Earnings/Sales Surprise)
- The gap between reported numbers and the analyst estimate. Positive earnings or sales surprises force analysts to raise their models - which often triggers weeks of follow-on buying.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ORZCF Orezone Gold Corporation | — | — | — | — | A+ 96 | — | 0.8 $ | Gold | Neutral | — | Basic Materials | 1.60 $ | — | — | +94.9 % | — | — | — | — | — | — | 1.29 | — | 4.0 | — | — | — | — | 4.9 | — | 54.9 % | 18.4 % | — | 14.0 % | — | — | +32.8 % | 6 | 0.0 % | 0.0 % | — | — | — | — | |
| RDDT Reddit, Inc. | 07/30 | — | 83 8/24 | Stage 4 | A 89 | 8 of 9 | 28.6 $ | Internet Content & Information | Sells AI | — | — | Communication Services | 140.70 $ | -27.9 % | -22.8 % | -12.4 % | −44.2 % | +55.1 % | 31 | 96 | 6.8 % | 6.8 % | 1.94 | 40.3 | 31.0 | 10.3 | 8.5 | 28.1 | 1.01 | 30.3 | 27.6 % | 91.4 % | 31.4 % | 26.2 % | 15.7 % | 0.01 | 91.3 % | +69.4 % | 8 | 0.0 % | 0.0 % | 21.0 | 93.6 % | 12.1 % | 3.9 (26) |
| CRDO Credo Technology Group Holding Ltd | 09/02 | +487 % | 72 7/25 | Stage 2 | A 87 | 7 of 9 | 38.5 $ | Semiconductors | Sells AI | — | Technology | 207.00 $ | +89.0 % | +63.6 % | +85.6 % | −13.2 % | +34.9 % | 96 | 93 | 10.5 % | 11.3 % | 3.20 | 83.7 | 35.1 | 28.8 | 18.8 | 94.6 | — | 77.5 | 35.7 % | 68.0 % | 35.4 % | 34.4 % | 17.9 % | 0.01 | 89.9 % | +205.7 % | 9 | 0.0 % | 0.0 % | 19.7 | 75.9 % | 3.6 % | 4.6 (13) | |
| DAVE Dave Inc | 08/05 | +2,117 % | 61 6/25 | Stage 2 | A 84 | 6 of 9 | 4.7 $ | Software - Application | Uses AI | — | Technology | 372.70 $ | +43.6 % | +62.5 % | +58.1 % | −5.8 % | +4.5 % | 83 | 86 | 8.5 % | 8.1 % | 3.83 | — | 22.7 | 7.8 | — | 14.4 | — | 22.1 | 38.3 % | 72.1 % | 37.2 % | 111.6 % | 32.0 % | — | 38.4 % | +59.7 % | 9 | 0.0 % | 0.0 % | 11.6 | 100.1 % | 21.0 % | 4.8 (8) | |
| STRL Sterling Construction Company Inc | 08/03 | +532 % | 48 6/29 | Stage 2 | A 82 | 7 of 9 | 19.1 $ | Engineering & Construction | Uses AI | — | — | Industrials | 596.80 $ | +191.4 % | +159.2 % | +123.0 % | −12.3 % | +58.6 % | 97 | 88 | 7.1 % | 7.5 % | 1.83 | 48.7 | 31.6 | 6.6 | 14.0 | 43.5 | 1.02 | 30.8 | 17.2 % | 23.3 % | 12.0 % | 36.7 % | 12.9 % | 0.57 | 42.7 % | +17.7 % | 5 | 0.0 % | 0.0 % | 6.7 | 95.7 % | 4.8 % | 5.0 (3) |
| PAYS Paysign Inc | 08/04 | +67 % | 80 8/25 | Stage 2 | A 81 | 6 of 9 | 0.5 $ | Software - Infrastructure | Neutral | — | — | Technology | 9.00 $ | +44.5 % | +55.2 % | +20.4 % | −13.1 % | +10.6 % | 90 | 84 | 5.4 % | 5.9 % | 0.72 | — | 37.3 | 5.6 | — | 7.3 | — | 23.4 | — | 60.4 % | 11.4 % | 22.1 % | 2.7 % | — | — | +40.5 % | 9 | 0.0 % | 0.0 % | 4.6 | 47.3 % | 3.5 % | 4.6 (5) |
| KRYS Krystal Biotech Inc | 08/03 | +62 % | 53 5/22 | Stage 2 | A 80 | 7 of 9 | 10.2 $ | Biotechnology | Uses AI | — | — | Healthcare | 341.10 $ | +38.0 % | +50.5 % | +121.7 % | −0.7 % | +12.7 % | 91 | 78 | 4.2 % | 3.9 % | 0.50 | 46.7 | 45.0 | 24.4 | 7.9 | 42.9 | — | 49.9 | 46.1 % | 94.2 % | 53.9 % | 19.9 % | 9.0 % | 0.01 | 91.4 % | +33.9 % | 7 | 0.0 % | 0.0 % | 19.8 | 99.4 % | 19.5 % | 4.6 (11) |
| AFRM Affirm Holdings Inc | 08/27 | +128 % | 53 5/22 | Stage 3 | A 79 | 8 of 9 | 24.1 $ | Credit Services | Uses AI | — | Financial Services | 71.50 $ | -3.5 % | +7.6 % | +4.3 % | −23.2 % | +26.7 % | 63 | 98 | 6.5 % | 6.1 % | 3.67 | 65.7 | 36.4 | 6.1 | 6.4 | 30.6 | 0.72 | 27.4 | 8.5 % | 48.4 % | 9.6 % | 11.5 % | 1.7 % | 2.74 | 28.8 % | +38.8 % | 6 | 0.0 % | 0.0 % | 9.1 | 86.9 % | 5.7 % | 4.2 (24) | |
| ALNY Alnylam Pharmaceuticals Inc | 07/30 | +17 % | 38 4/22 | Stage 4 | A 79 | 7 of 9 | 27.3 $ | Biotechnology | Uses AI | — | Healthcare | 205.50 $ | -27.5 % | -26.7 % | -47.6 % | −40.8 % | +88.0 % | 17 | 42 | 3.4 % | 3.4 % | 0.27 | 51.2 | 23.4 | 5.7 | 25.4 | — | 0.37 | 23.0 | 23.0 % | 79.7 % | 16.1 % | 90.4 % | 12.3 % | 1.18 | 21.0 % | +65.2 % | 8 | 0.0 % | 0.0 % | 4.2 | 102.1 % | 5.8 % | 4.2 (30) | |
| AMSC American Superconductor Corporation | 07/29 | +203 % | 60 7/29 | Stage 3 | A 79 | 6 of 9 | 1.6 $ | Specialty Industrial Machinery | Neutral | — | — | Industrials | 29.40 $ | +44.6 % | +27.1 % | -48.3 % | −42.9 % | +112.6 % | 66 | 91 | 7.0 % | 7.9 % | 3.22 | — | 28.3 | 5.2 | — | 84.9 | 0.74 | 53.4 | 5.1 % | 30.8 % | 44.7 % | 35.6 % | 2.1 % | — | 75.1 % | +34.3 % | 5 | 0.0 % | 0.0 % | 4.2 | 69.8 % | 7.3 % | 4.7 (3) |
| AVPT Avepoint Inc | 08/06 | +23 % | 73 7/25 | Stage 4 | A 79 | 8 of 9 | 2.7 $ | Software - Infrastructure | Sells AI | — | Technology | 13.00 $ | -25.8 % | -18.5 % | -31.7 % | −48.1 % | +24.6 % | 14 | 93 | 4.8 % | 4.4 % | 1.16 | — | 0.0 | 6.2 | — | 26.2 | — | 47.8 | 10.9 % | 73.7 % | 10.5 % | 11.7 % | 4.0 % | — | 59.8 % | +26.9 % | 8 | 0.0 % | 0.0 % | 5.6 | 73.7 % | 7.1 % | 4.4 (8) | |
| ELA Envela Corp | 08/05 | +95 % | 94 13/31 | Stage 2 | A 79 | 8 of 9 | 0.6 $ | Luxury Goods | Neutral | — | Consumer Cyclical | 21.70 $ | +100.4 % | +120.5 % | +300.0 % | −9.2 % | +17.5 % | 96 | 92 | 6.6 % | 6.7 % | 0.37 | 27.2 | 54.1 | 1.9 | 7.4 | 26.7 | — | 18.7 | — | 21.5 % | 7.2 % | 32.0 % | 17.5 % | 0.26 | — | +33.6 % | 5 | 0.0 % | 0.0 % | 11.9 | 19.6 % | 4.9 % | 5.0 (2) | |
| AGX Argan Inc | — | +629 % | 85 10/29 | Stage 2 | A 78 | 5 of 9 | 8.6 $ | Engineering & Construction | Uses AI | — | — | Industrials | 570.40 $ | +135.6 % | +141.6 % | +134.0 % | −4.8 % | +19.2 % | 96 | 86 | 7.0 % | 7.0 % | 0.56 | 50.9 | 16.6 | 8.2 | 16.9 | 17.6 | — | 43.3 | 15.6 % | 20.7 % | 15.5 % | 38.5 % | 9.4 % | — | 36.8 % | +8.1 % | 8 | 0.4 % | 17.6 % | 8.1 | 108.9 % | 6.7 % | 4.0 (2) |
| VICR Vicor Corporation | 07/28 | +178 % | 78 8/25 | Stage 2 | A 78 | 5 of 9 | 10.3 $ | Electronic Components | Neutral | — | Technology | 207.40 $ | +206.7 % | +238.2 % | +366.6 % | −10.2 % | +86.2 % | 99 | 96 | 9.3 % | 9.4 % | 2.34 | 68.4 | 68.0 | 21.8 | 12.4 | 117.6 | — | 83.2 | 15.0 % | 56.6 % | 30.7 % | 20.5 % | 7.5 % | 0.01 | 93.7 % | +13.6 % | 8 | 0.0 % | 0.0 % | 26.2 | 63.3 % | 6.3 % | 3.3 (4) | |
| IESC IES Holdings Inc | 08/07 | +416 % | 59 7/29 | Stage 2 | A 78 | 6 of 9 | 15.8 $ | Engineering & Construction | Neutral | — | — | Industrials | 744.50 $ | +82.6 % | +77.9 % | +110.9 % | −4.7 % | -6.0 % | 92 | 79 | 7.0 % | 6.3 % | 1.78 | 37.1 | 208.3 | 4.0 | 12.9 | 44.8 | — | 22.7 | 11.5 % | 26.3 % | 11.4 % | 42.1 % | 16.5 % | 0.11 | 53.8 % | +16.9 % | 7 | 0.0 % | 0.0 % | 9.3 | 96.9 % | 8.7 % | — |
| ATEX Anterix Inc | 08/11 | +51 % | 89 9/24 | Stage 2 | A 78 | 7 of 9 | 1.8 $ | Telecom Services | Neutral | — | Communication Services | 93.00 $ | +266.4 % | +339.9 % | +318.8 % | −8.1 % | +15.8 % | 97 | 85 | 8.3 % | 8.2 % | 0.83 | 21.3 | 0.0 | 266.2 | 7.7 | 319.5 | — | -12.4 | — | 100.0 % | 1,394.2 % | 43.3 % | -6.5 % | 0.02 | — | +7.8 % | 6 | 0.0 % | 0.0 % | 3.5 | 91.8 % | 16.9 % | 4.7 (3) | |
| ELMD Electromed Inc | 08/25 | +80 % | 82 7/22 | Stage 2 | A 78 | 7 of 9 | 0.3 $ | Medical Devices | Neutral | — | Healthcare | 40.60 $ | +32.3 % | +47.0 % | +123.7 % | −2.3 % | -0.7 % | 87 | 81 | 5.2 % | 5.7 % | 0.50 | 35.9 | 20.2 | 4.7 | 6.8 | 33.1 | 0.35 | 22.4 | — | 78.4 % | 14.1 % | 21.7 % | 14.9 % | — | — | +17.0 % | — | 0.0 % | 0.0 % | 15.6 | 59.1 % | 2.5 % | 5.0 (3) | |
| FICO Fair Isaac Corporation | 07/29 | +14 % | 72 7/25 | Stage 4 | A 77 | 7 of 9 | 26.0 $ | Software - Application | Sells AI | — | — | Technology | 1,123.00 $ | -35.0 % | -32.0 % | -21.8 % | −42.8 % | +34.0 % | 15 | 81 | 4.2 % | 5.0 % | 1.29 | 36.8 | 20.5 | 10.9 | 80.9 | 26.2 | 0.77 | 23.4 | 58.2 % | 85.1 % | 34.1 % | 35.6 % | 40.0 % | -1.27 | -102.6 % | +15.9 % | 7 | 0.0 % | 0.0 % | 16.0 | 95.8 % | 11.4 % | 3.8 (19) |
| SITM Sitime Corporation | 08/05 | +172 % | 72 7/25 | Stage 2 | A 77 | 7 of 9 | 15.1 $ | Semiconductors | Sells AI | — | — | Technology | 535.20 $ | +100.1 % | +87.9 % | +163.8 % | −25.1 % | +56.5 % | 95 | 12 | 8.0 % | 7.5 % | 2.91 | — | 71.9 | 39.6 | 12.1 | 278.7 | 3.82 | 3,076.2 | -4.2 % | 55.7 % | -6.4 % | -2.6 % | -2.3 % | 0.00 | 89.6 % | +61.2 % | 5 | 0.0 % | 0.0 % | 16.1 | 89.0 % | 5.0 % | 3.9 (7) |
| INCY Incyte Corporation | 08/04 | +22 % | 88 8/22 | Stage 2 | A 77 | 7 of 9 | 23.7 $ | Biotechnology | Uses AI | — | Healthcare | 119.50 $ | +5.7 % | +14.2 % | +59.6 % | −4.2 % | +2.9 % | 66 | 83 | 4.3 % | 3.7 % | 0.76 | 17.9 | 38.5 | 4.4 | 4.5 | 16.3 | 28.47 | 9.5 | 25.6 % | 55.7 % | 27.7 % | 30.8 % | 16.8 % | 0.01 | 75.6 % | +21.2 % | 8 | 0.0 % | 0.0 % | 11.9 | 106.6 % | 9.1 % | 3.7 (27) | |
| NBIX Neurocrine Biosciences Inc | 07/29 | +23 % | 67 6/22 | Stage 2 | A 77 | 6 of 9 | 16.8 $ | Drug Manufacturers - Specialty & Generic | Uses AI | — | Healthcare | 166.80 $ | +13.8 % | +15.7 % | +30.1 % | −3.2 % | +26.6 % | 65 | 98 | 2.9 % | 2.9 % | 0.39 | 26.3 | 23.5 | 5.0 | 4.9 | 19.3 | 0.47 | 18.2 | 22.8 % | 64.5 % | 20.9 % | 22.5 % | 11.7 % | 0.12 | 69.5 % | +21.5 % | 9 | 0.0 % | 0.0 % | 9.4 | 103.9 % | 6.9 % | 4.5 (25) | |
| DUOL Duolingo Inc | 08/05 | -2 % | 79 8/25 | Stage 3 | A 77 | 4 of 9 | 6.0 $ | Software - Application | Sells AI | — | Technology | 134.80 $ | -24.7 % | -35.8 % | -61.1 % | −74.4 % | -14.8 % | 16 | 68 | 6.5 % | 6.5 % | 0.88 | 16.1 | 20.0 | 5.5 | 5.0 | 14.5 | — | 29.9 | 15.4 % | 72.7 % | 38.4 % | 37.0 % | 5.9 % | 0.07 | 67.6 % | +38.7 % | 7 | 0.0 % | 0.0 % | 9.6 | 98.5 % | 21.4 % | 3.9 (23) | |
| INVA Innoviva Inc | 08/05 | +29 % | 70 6/22 | Stage 2 | A 77 | 6 of 9 | 1.5 $ | Biotechnology | Uses AI | — | Healthcare | 21.00 $ | +17.8 % | +17.0 % | +15.4 % | −7.1 % | +69.0 % | 54 | 95 | 2.8 % | 2.8 % | 0.34 | — | 10.7 | 3.5 | — | 8.2 | 0.31 | 1.9 | 40.1 % | 74.1 % | 119.9 % | 50.7 % | 6.7 % | — | 73.1 % | +18.5 % | 7 | 0.0 % | 0.0 % | 11.8 | 108.0 % | 12.8 % | 4.0 (1) | |
| IDR Idaho Strategic Resources Inc | 08/06 | +168 % | — | Stage 1 | A 77 | 7 of 9 | 0.0 $ | Gold | Neutral | — | Basic Materials | 28.10 $ | -18.9 % | -31.5 % | +71.2 % | −40.5 % | +38.3 % | 72 | 50 | 8.4 % | 8.0 % | 1.21 | 23.3 | 22.0 | — | 4.5 | — | — | 18.9 | — | 69.7 % | 43.3 % | 26.5 % | 15.7 % | 0.02 | — | +64.6 % | 7 | 0.0 % | 0.0 % | 25.9 | 46.7 % | 8.0 % | — | |
| ROKU Roku Inc | 07/30 | +39 % | 35 4/24 | Stage 2 | A 76 | 8 of 9 | 21.6 $ | Entertainment | Uses AI | — | Communication Services | 145.00 $ | +24.5 % | +23.4 % | +54.0 % | −9.5 % | +9.2 % | 80 | 10 | 2.0 % | 4.0 % | 2.01 | 108.1 | 62.5 | 4.4 | 8.1 | 33.1 | 1.03 | 34.6 | 4.3 % | 44.2 % | 4.1 % | 7.8 % | 1.6 % | 0.21 | 61.4 % | +15.2 % | 4 | 0.0 % | 0.0 % | 7.5 | 88.2 % | 7.2 % | 3.8 (32) | |
| SEZL Sezzle Inc. | 08/06 | — | 70 6/22 | Stage 2 | A 76 | 6 of 9 | 5.4 $ | Credit Services | Uses AI | — | Financial Services | 154.80 $ | +138.8 % | +131.8 % | -0.1 % | −12.3 % | +5.7 % | 91 | 76 | 8.0 % | 7.4 % | 6.72 | 22.2 | 30.3 | 11.2 | 15.9 | 22.5 | 0.11 | 28.5 | 61.0 % | 74.3 % | 30.8 % | 92.0 % | 47.5 % | 0.74 | 43.3 % | +66.1 % | 9 | 0.0 % | 0.0 % | 11.4 | 40.9 % | 23.2 % | 5.0 (2) | |
| FIVN Five9 Inc | 07/30 | -25 % | 61 6/25 | Stage 3 | A 76 | 9 of 9 | 2.1 $ | Software - Infrastructure | Sells AI | — | Technology | 27.50 $ | -4.9 % | +8.1 % | +6.5 % | −34.3 % | +0.2 % | 27 | 98 | 5.7 % | 6.9 % | 1.46 | 46.2 | 8.4 | 1.8 | 2.8 | 10.6 | 0.24 | 15.2 | 6.1 % | 55.5 % | 4.9 % | 7.7 % | 2.2 % | 0.97 | 44.5 % | +10.3 % | 5 | 0.0 % | 0.0 % | 6.5 | 105.3 % | 10.3 % | 4.3 (24) | |
| DXCM DexCom Inc | 07/29 | -15 % | 38 4/22 | Stage 2 | A 75 | 9 of 9 | 32.2 $ | Medical Devices | Uses AI | — | Healthcare | 83.50 $ | +3.8 % | +3.8 % | +3.3 % | −23.7 % | +11.1 % | 35 | 85 | 3.2 % | 4.1 % | 1.45 | 36.6 | 32.6 | 6.5 | 10.9 | 22.9 | 1.56 | 19.8 | 21.4 % | 62.5 % | 20.1 % | 35.6 % | 10.3 % | 0.47 | 44.6 % | +15.6 % | 7 | 0.0 % | 0.0 % | 8.7 | 102.5 % | 5.6 % | 4.7 (27) | |
| MTZ MasTec Inc | 07/30 | +84 % | — | Stage 2 | A 75 | 9 of 9 | 0.0 $ | Engineering & Construction | – | — | — | Industrials | 263.10 $ | +79.6 % | +92.0 % | +39.1 % | −8.6 % | +15.8 % | 90 | 50 | 5.2 % | 4.9 % | 1.77 | 54.2 | 42.9 | — | 7.4 | — | 1.68 | 26.5 | 3.7 % | 12.8 % | 2.9 % | 15.0 % | 4.9 % | 3.15 | 31.7 % | +16.2 % | 6 | 0.0 % | 0.0 % | 5.8 | 75.8 % | 5.9 % | 1.2 (17) |
| FORM FormFactor Inc | 07/29 | +126 % | 87 9/25 | Stage 2 | A 75 | 8 of 9 | 9.1 $ | Semiconductor Equipment & Materials | Uses AI | — | — | Technology | 106.20 $ | +156.0 % | +147.9 % | +273.8 % | −6.5 % | +30.5 % | 97 | 91 | 9.4 % | 8.6 % | 1.22 | 107.3 | 39.5 | 10.8 | 6.9 | 248.1 | 1.39 | 44.7 | 17.7 % | 46.2 % | 12.8 % | 6.8 % | 7.3 % | 0.04 | 84.3 % | +2.8 % | 5 | 0.0 % | 0.0 % | 12.3 | 98.8 % | 5.1 % | 3.7 (10) |
| IOT Samsara Inc | 09/03 | +7 % | 45 5/25 | Stage 4 | A 75 | 8 of 9 | 21.6 $ | Software - Infrastructure | Sells AI | — | Technology | 37.30 $ | -11.7 % | -12.2 % | -2.0 % | −39.0 % | +18.8 % | 19 | 42 | 5.7 % | 6.6 % | 1.35 | 400.8 | 52.4 | 12.5 | 15.5 | 92.1 | — | 1,426.6 | 1.5 % | 76.3 % | 3.3 % | 4.4 % | -0.3 % | 0.05 | 57.7 % | +29.6 % | 7 | 0.0 % | 0.0 % | 4.3 | 102.6 % | 12.6 % | 4.0 (21) | |
| LQDA Liquidia Technologies Inc | 08/11 | +241 % | 93 9/22 | Stage 2 | A 75 | 7 of 9 | 7.5 $ | Drug Manufacturers - Specialty & Generic | Neutral | — | — | Healthcare | 84.10 $ | +114.7 % | +109.9 % | +350.0 % | −1.7 % | +0.9 % | 98 | 42 | 6.2 % | 6.4 % | 0.55 | 502.7 | 21.2 | 26.0 | 70.0 | 181.4 | — | 138.3 | 46.3 % | 91.8 % | 7.7 % | 28.2 % | 9.0 % | 1.70 | 27.0 % | +1,031.2 % | 6 | 0.0 % | 0.0 % | 2.9 | 70.2 % | 17.2 % | 4.3 (10) |
| EVER EverQuote Inc Class A | 08/03 | +73 % | 63 6/24 | Stage 3 | A 75 | 8 of 9 | 0.9 $ | Internet Content & Information | Uses AI | — | Communication Services | 25.20 $ | -23.1 % | -12.9 % | +2.6 % | −24.5 % | +4.0 % | 35 | 88 | 5.8 % | 5.8 % | 0.60 | 9.2 | 11.1 | 1.2 | 4.0 | 9.0 | — | 9.2 | — | 97.5 % | 15.4 % | 56.4 % | 16.7 % | 0.01 | — | +38.5 % | 9 | 0.0 % | 0.0 % | 10.8 | 97.2 % | 21.8 % | 4.3 (8) | |
| GRND Grindr Inc | 08/06 | +45 % | 87 9/25 | Stage 3 | A 75 | 7 of 9 | 3.1 $ | Software - Application | Uses AI | — | — | Technology | 17.30 $ | -3.0 % | +5.9 % | -0.8 % | −41.0 % | +8.7 % | 22 | 80 | 5.4 % | 4.8 % | 0.22 | 39.8 | 0.0 | 6.5 | 3,875.5 | 21.2 | — | 23.1 | — | 74.7 % | 19.9 % | 58.9 % | 16.3 % | 23.84 | — | +27.6 % | 8 | 0.0 % | 0.0 % | 5.0 | 21.4 % | 18.2 % | 4.3 (4) |
| ASIC Ategrity Specialty Insurance Company Holdings | — | — | — | — | A 75 | 6 of 9 | 1.2 $ | Insurance - Property & Casualty | Uses AI | — | Financial Services | 24.00 $ | +17.3 % | +41.9 % | +20.2 % | −3.7 % | +18.8 % | — | — | — | — | — | 12.7 | 9.9 | 2.5 | 1.9 | 7.4 | — | 0.0 | 26.6 % | 28.4 % | 20.7 % | 17.9 % | 6.0 % | 0.00 | 41.7 % | +23.4 % | 7 | 0.0 % | 0.0 % | 1.3 | 12.6 % | 2.6 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Our own Fundamental Rating (0…100 points, rank A+…F; 50 points = the average of the universe) in the style of professional screener platforms: every stock is percentile-ranked against all others — historical & recent EPS/revenue growth (EPS = earnings per share), EPS surprise, forward EPS, plus quality (acceleration, margin + margin expansion, Piotroski, FCF, earnings stability, OCF positivity, balance sheet safety, …
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 35 stocks pass this scanner's criteria (as of 3. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- Altman Z: Balance Sheet Fortress
- Buffett Criteria (Buffettology)
- Buffett: Owner Earnings Yield
- CEO Buys
- FCF/Market Cap
- Insider Buying (Net)
- Institutional + Insiders Building Positions
- Institutional Accumulation
- Institutions + CEO Buying
- Levermann
- Mark Minervini Code 33
- Mike Webster: Recession Proof
- Piotroski F-Score (7–9)
- Pros 80%
- QARP — Quality at a Fair Price
- Terry Smith: Quality (Fundsmith Criteria)
- U/D Accumulation
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.